Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study
about
A genome-wide association study of carotid atherosclerosis in HIV-infected menRole of high-sensitivity C-reactive protein measurements in HIV patientsFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVAssociation of low level viremia with inflammation and mortality in HIV-infected adultsAtherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections.Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.Complete blood count, measures of iron status and inflammatory markers in inner-city African Americans with undiagnosed hepatitis C seropositivity.Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infectionThe consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients.Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.Biomarkers and HIV-associated cardiovascular disease.Chronic HIV disease and activation of the coagulation systemChanges in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy.Biomarkers of immune dysfunction in HIV.HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologiesDifferent plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individualsHIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infectionChange in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.The macrophage: the intersection between HIV infection and atherosclerosis.The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfectionPossible Biomarkers for the Early Detection of HIV-associated Heart Diseases: A Proteomics and Bioinformatics PredictionAssociation of antiretroviral therapy with fibrinogen levels in HIV-infection.Epidemiology and management of antiretroviral-associated cardiovascular disease.The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levelsHIV infection is associated with decreased thrombin generationImpact of hepatitis C on survival of HIV-infected individuals in Shiraz; South of Iran.Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy.Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy.Current understanding of HIV-associated neurocognitive disorders pathogenesis.Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy.
P2860
Q24622468-CD495C84-58D8-48DE-A6CF-5334BB240A18Q28067891-E391F37C-C223-4AB1-8A55-A59F5FD5F778Q28079826-15CD64AA-6331-423B-A43B-3FB71D418311Q28743237-C69D45B0-5080-477F-B997-8DD60CFF2109Q30248286-6FB5706C-3E90-441B-B1B0-8842704CA25CQ30558355-467C1889-F891-4A10-8A47-24B98738E827Q31127335-D94EE59C-622B-4699-81F6-AF7C2F8E99A5Q31149395-A7D611B7-6CD7-46EC-A929-A70694D6F314Q33388034-6C966369-4E91-4ED0-8306-30AFEE864DF4Q33857515-1437F781-A240-4854-9730-E775E4D8ADDCQ33889580-D365225D-F7F1-415F-B4B9-3F1A14013B45Q34130371-DE87F5F5-49A4-4BF7-8140-90B89FCC4B42Q34204026-5DA24A2B-86B3-40BA-95AA-AF57F8804833Q34335486-F47F9E04-AA89-4B5F-9569-4D97CCFCD57AQ34342368-10D9F8E1-A04E-4FCB-A5A5-B4480ED8C84DQ34423991-F6795834-CEBB-4E05-B0C0-369B1B1EF737Q34509012-277E9D87-0FBD-4ACB-B1E6-BAB1F2C03E08Q34546742-4DAFC1F9-D9E7-4C20-880A-1446744889A4Q34561257-F236757C-95CE-4BB5-8DF7-D8F945795F74Q34612385-32355262-1CED-421A-9546-5FBDCE15DD67Q34712485-B69BF3CB-FFCE-4833-9F48-291E4A2968C0Q34875287-02C656B5-F502-4BC3-8927-B8FD39563D5AQ34898069-8210BA8F-60F3-4543-A646-92DFF3880E79Q35072020-01DD6269-7655-4E1B-9722-A8D77D0E4AB3Q35143657-19BB2F08-DFBB-4A18-BE27-533DB6E03864Q35166181-D404895E-9392-483B-BFB6-19D021B645CEQ35338096-8CCF10B8-573A-49EC-88ED-4D049E3DDA76Q35590977-1FE2BB61-57BB-4071-B128-979D6AD93BA0Q35772369-DD9FB421-1211-4BD8-A69C-C9ABDFCC2F50Q35845337-0257905A-DD3A-495E-A0B8-B1CE7B446822Q35875249-846F1BFD-4458-4C73-AC0D-D08BB8E0C183Q35979650-E485F2FF-D06D-46D1-9D4F-76C7661F77E0Q36104762-9F9BF959-D1B2-40AB-873C-C4984A7F8E93Q36445470-38025DDF-8A1A-4A9C-A5EE-43B37E60CC64Q36578046-EEC4EC0F-2BB4-4E0A-BF01-C592E0E4136FQ36654566-32006289-8857-45A2-AC80-F7714900CFDEQ36687721-180FF400-41EE-463B-B75D-D2C295AE8A96Q36775142-48B73AD0-56E1-41CB-8C1C-352D92603261Q36932005-36AA85DB-72DE-4DF4-8DA1-2E909A0846EDQ36937853-9B52F498-A88E-471C-B06C-31D6B143B1F5
P2860
Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Association of HIV infection a ...... in HIV infection (FRAM) study
@en
type
label
Association of HIV infection a ...... in HIV infection (FRAM) study
@en
prefLabel
Association of HIV infection a ...... in HIV infection (FRAM) study
@en
P2093
P2860
P50
P1476
Association of HIV infection a ...... in HIV infection (FRAM) study
@en
P2093
Carl Grunfeld
Christine Wanke
Donald Kotler
Jason Reingold
Peter Bacchetti
Phyllis Tien
Rebecca Scherzer
Russell Tracy
P2860
P304
P356
10.1097/QAI.0B013E3181685727
P407
P577
2008-06-01T00:00:00Z